UK Markets close in 28 mins

Zealand Pharma A/S (ZLDPF)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
31.650.00 (0.00%)
As of 10:23AM EDT. Market open.
Full screen
Trade prices are not sourced from all markets
Previous close31.65
Open31.65
BidN/A x N/A
AskN/A x N/A
Day's range31.65 - 31.65
52-week range27.85 - 37.80
Volume200
Avg. volume6
Market cap1.376B
Beta (5Y monthly)0.85
PE ratio (TTM)N/A
EPS (TTM)N/A
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
All
News
  • Globe Newswire

    Total number of shares and voting rights in Zealand Pharma at September 30, 2021

    Company announcement – No. 62 / 2021 Total number of shares and voting rights in Zealand Pharma at September 30, 2021 Copenhagen, DK and Boston, MA, September 30, 2021 – Zealand Pharma A/S (“Zealand”) (NASDAQ: ZEAL) (CVR-no. 20 04 50 78), a biotechnology company focused on the discovery, development and commercialization of innovative peptide-based medicines, in accordance with section 32 of the Danish Capital Markets Act, announces the total number of shares and voting rights in the Company at

  • Globe Newswire

    Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons

    Company announcement – No. 61 / 2021 Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons Copenhagen, DK and Boston, MA, U.S., September 10, 2021 – Zealand Pharma A/S (“Zealand”) (Nasdaq: ZEAL) (CVR-no. 20045078), a biotechnology company focused on the discovery, development and commercialization of innovative peptide-based medicines, has received information on transactions in Zealand's shares

  • Globe Newswire

    Zealand Pharma increases its share capital as a consequence of exercise of employee warrants

    Company announcement – No. 60 / 2021 Zealand Pharma increases its share capital as a consequence of exercise of employee warrants Copenhagen, DK and Boston, MA, U.S. September 10, 2021 – Zealand Pharma A/S (Nasdaq: ZEAL) (CVR-no. 20045078), a biotechnology company focused on the discovery, development and commercialization of innovative peptide-based medicines, has increased its share capital by a nominal amount of DKK 30,748 divided into 30,748 new shares with a nominal value of DKK 1 each. The